Company Encyclopedia
View More
name
Zhengchuan Pharmapack
603976.SH
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China and internationally. It offers neutral borosilicate glass ampoule and tube injection bottles, low borosilicate tubular vial and ampoule bottles, oral liquid vials, and screw neck vials. The company also provides aluminum caps, aluminum-plastic composite caps, and other medicinal caps. Its products are used in biological preparations, traditional Chinese medicine preparations, and chemical medicines.
340.34 B
603976.SHMarket value -Rank by Market Cap -/-

Financial Score

22/12/2025 Update
C
Health Care SuppliesIndustry
Industry Ranking32/41
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.46%C
    • Profit Margin2.72%C
    • Gross Margin19.31%D
  • Growth ScoreE
    • Revenue YoY-22.94%E
    • Net Profit YoY-68.76%E
    • Total Assets YoY-4.31%D
    • Net Assets YoY-1.60%D
  • Cash ScoreC
    • Cash Flow Margin3678.78%A
    • OCF YoY-22.94%E
  • Operating ScoreD
    • Turnover0.34D
  • Debt ScoreB
    • Gearing Ratio36.42%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Zhengchuan Pharmapack: The net profit for the third quarter was 2.251 million yuan, a year-on-year decrease of 70.23%

    Zhengchuan Pharmapack announced that the revenue for the third quarter was 134 million yuan, a year-on-year decrease of 9.98%; the net profit was 2.251 million yuan, a year-on-year decrease of 70.23%. The revenue for the first three quarters was 458 million yuan, a year-on-year decrease of 24.92%; the net profit was 16.3393 million yuan, a year-on-year decrease of 68.54%

    Zhitong·
    SH
    603976
    -0.25%
    Zhitong·
    SH
    603976
    -0.25%

    The medical device sector continues to rise, with Zhengchuan Pharmapack and CONTEC both hitting the daily limit

    The medical device sector continues to rise, with Zhengchuan Pharmapack and CONTEC both hitting the daily limit, Nanwei Medical rising over 10%, and Lude Medical, Shandong Pharmaceutical Glass, Anjiasi, Jinhao Medical, and Maipu Medical also following suit

    Zhitong·
    SZ
    300869
    -0.06%
    SH
    603976
    -0.25%
    Zhitong·
    SZ
    300869
    -0.06%
    SH
    603976
    -0.25%

    Zhengchuan Pharmapack: 50 million yuan of idle funds invested in structured deposits at INDUSTRIAL BANK

    Chongqing Zhengchuan Pharmapack Co., Ltd. announced that it plans to invest 50 million yuan of idle funds in structured deposits at INDUSTRIAL BANK, with a term of 92 days and an expected annualized yield of 1.00%-1.95%. This investment has been reviewed and approved by the board of directors and the supervisory board, aiming to improve the efficiency of fund utilization without affecting daily operations, and the risks are controllable

    Zhitong·
    SH
    601166
    -0.47%
    SH
    603976
    -0.25%
    Zhitong·
    SH
    601166
    -0.47%
    SH
    603976
    -0.25%

    Zhengchuan Pharmapack: Expected net profit for the first half of 2025 to decrease by 66.20%-77.47% year-on-year

    Zhengchuan Pharmapack expects its net profit for the first half of 2025 to decrease by 66.20% year-on-year to 77.47 million yuan, with a net profit attributable to shareholders of the listed company expected to be between 10 million yuan and 15 million yuan, a decrease of 29.3798 million yuan to 34.3798 million yuan compared to the same period last year. The net profit after deducting non-recurring gains and losses is expected to be between 7 million yuan and 10.5 million yuan, a year-on-year decrease of 74.25% to 82.83%

    Zhitong·
    SH
    603976
    -0.25%
    Zhitong·
    SH
    603976
    -0.25%

    The medical device sector saw a short-term surge, with NANFANG MEDICAL hitting the daily limit

    The medical device sector saw a short-term surge, with NANFANG MEDICAL hitting the daily limit, and Hob Biotech, SSSW, Zhengchuan Pharmapack, Rejing Biotech, and Edan all rising

    Zhitong·
    SH
    688399
    -0.65%
    SH
    603976
    -0.25%
    SZ
    300206
    -0.54%
    Zhitong·
    SH
    688399
    -0.65%
    SH
    603976
    -0.25%
    SZ
    300206
    -0.54%
    © 2025 Longbridge｜Disclaimer